A switchable phototherapeutic strategy based on a hypoxia-responsive photosensitizer for heterogeneous tumor ablation
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer, Hypoxia, and Metabolism · Photodynamic Therapy Research Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (44)
Show source-provided references
1. The challenges for cancer chemoprevention10.1039/C5CS00705D ↗
2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
3. ROS-responsive camptothecin prodrug nanoparticles for on-demand drug release and combination of chemotherapy and photodynamic therapy10.1002/adfm.202005918 ↗
4. On/off switchable epicatechin-based ultra-sensitive MRI-visible nanotheranostics - see it and treat it10.1039/D0BM00842G ↗
5. Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies10.1007/s10555-015-9588-7 ↗
6. Recent advances in tumor microenvironment hydrogen peroxide-responsive materials for cancer photodynamic therapy10.1007/s40820-019-0347-0 ↗
7. In situ monitoring apoptosis process by a self-reporting photosensitizer10.1021/jacs.9b00636 ↗
8. Nanoparticles in photodynamic therapy10.1021/cr5004198 ↗
9. A review of progress in clinical photodynamic therapy10.1177/153303460500400308 ↗
10. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application10.1039/D0CS00173B ↗
11. Direct near-infrared luminescence detection of singlet oxygen generated by photodynamic therapy in cells in vitro and tissues in vivo10.1562/0031-8655(2002)0750382DNILDO2.0.CO2 ↗
12. How does photodynamic therapy work?10.1111/j.1751-1097.1992.tb04222.x ↗
13. Photodynamic therapy - mechanisms, photosensitizers and combinations10.1016/j.biopha.2018.07.049 ↗
14. Functionalized fullerenes mediate photodynamic killing of cancer cells: type I versus type II photochemical mechanism10.1016/j.freeradbiomed.2007.05.005 ↗
15. Development of an azo-based photosensitizer activated under mild hypoxia for photodynamic therapy10.1021/jacs.7b05019 ↗
16. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review
17. Ultrasensitive nanosensors based on upconversion nanoparticles for selective hypoxia imaging in vivo upon near-infrared excitation10.1021/ja5042989 ↗
18. Tumor microenvironment and the response to anticancer therapy10.4161/cbt.1.5.157 ↗
19. An aza-BODIPY photosensitizer for photoacoustic and photothermal imaging guided dual modal cancer phototherapy10.1039/C6TB02979E ↗
20. Nitroreductase-activatable theranostic molecules with high PDT efficiency under mild hypoxia based on a TADF fluorescein derivative10.1021/acsami.9b04488 ↗
21. A self-activating nanovesicle with oxygen-depleting capability for efficient hypoxia-responsive chemo-thermo cancer therapy10.1016/j.biomaterials.2020.120533 ↗
22. Multifunctional supramolecular vesicles for combined photothermal/photodynamic/hypoxia-activated chemotherapy10.1039/C8CC05560B ↗
23. Cascade reactions by nitric oxide and hydrogen radical for anti-hypoxia photodynamic therapy using an activatable photosensitizer10.1021/jacs.0c10517 ↗
24. Platinum nanoenzyme functionalized black phosphorus nanosheets for photothermal and enhanced-photodynamic therapy10.1016/j.cej.2020.127381 ↗
25. Strategies for maximizing photothermal conversion efficiency based on organic dyes10.1016/j.drudis.2021.03.009 ↗
26. Dissecting the molecular mechanism of apoptosis during photothermal therapy using gold nanoprisms10.1021/nn505468v ↗
27. Bioreductive fluorescent imaging agents: applications to tumour hypoxia10.1039/C6CC01037G ↗
28. Ultrasensitive near-infrared fluorescence-enhanced probe for in vivo nitroreductase imaging10.1021/jacs.5b04097 ↗
29. A new prodrug-derived ratiometric fluorescent probe for hypoxia: high selectivity of nitroreductase and imaging in tumor cell10.1021/ol102975t ↗
30. Hypoxia-activated NIR photosensitizer anchoring in the mitochondria for photodynamic therapy10.1039/C9SC03355F ↗
31. A probe for the detection of hypoxic cancer cells10.1021/acssensors.7b00171 ↗
32. Design of BODIPY dyes as triplet photosensitizers: electronic properties tailored for solar energy conversion, photoredox catalysis and photodynamic therapy10.1039/D1SC00732G ↗
33. Organic molecule-based photothermal agents: an expanding photothermal therapy universe10.1039/C7CS00522A ↗
34. Oxygen-dependent regulation of excited-state deactivation process of rational photosensitizer for smart phototherapy10.1021/jacs.9b11800 ↗
35. MoO3-x nanosheets-based platform for single NIR laser induced efficient PDT/PTT of cancer10.1016/j.jconrel.2021.08.022 ↗
36. Activatable water-soluble probes enhance tumor imaging by responding to dysregulated pH and exhibiting high tumor-to-liver fluorescence emission contrast10.1021/acs.bioconjchem.6b00242 ↗
37. Photophysical and optical limiting properties of a novel distyryl-BODIPY with fused crown ether moieties10.1142/S1088424617500869 ↗
38. An AIE-based probe for rapid and ultrasensitive imaging of plasma membranes in biosystems10.1002/anie.201909498 ↗
39. Crystal structure of FMN-dependent nitroreductase from escherichia coli B: a prodrug-activating enzyme10.1021/jm000159m ↗
40. Strategies for enzyme/prodrug cancer therapy
41. Mitochondrial nitroreductase activity enables selective imaging and therapeutic targeting10.1021/jacs.6b06229 ↗
42. Singlet oxygen "afterglow" therapy with NIR-II fluorescent molecules10.1002/adma.202103627 ↗
43. Innovative strategies for hypoxic-tumor photodynamic therapy10.1002/anie.201805138 ↗
44. Real-time bioluminescence imaging of nitroreductase in mouse model10.1021/acs.analchem.6b01160 ↗